AMBALALSAPharmaceuticals
Ambalal Sarabhai Enterprises Ltd — PE Ratio & Valuation Analysis
₹24.27
-4.23%
Current P/E13.99xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E72.4x80.7% below avg
✅
56.0% Discount to Industry
AMBALALSA P/E 13.99x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹0.74 | ₹54 | 72.4x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Ambalal Sarabhai Enterprises Ltd Valuation
Ambalal Sarabhai Enterprises Ltd (AMBALALSA) currently trades at 13.99x earnings. The Pharmaceuticals sector average PE is 31.77x. AMBALALSA is trading at a discount to peers — may indicate relative value. Historically, AMBALALSA has traded at an average PE of 72.4x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
6.25%
Dividend Yield
0.00%
More on Ambalal Sarabhai Enterprises Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.